Introduction: Transurethral resection of the prostate is one of the most common surgical procedures performed in men to relieve bladder outlet obstruction, most often due to benign prostatic hyperplasia. However, transurethral resection of the prostate may also be used in patients with metastatic prostate cancer who have bladder outlet obstruction. Acute kidney injury after transurethral resection of the prostate has been described and attributed to a variety of mechanisms, including acute tubular necrosis, rhabdomyolysis, and hemolysis with heme-pigment nephropathy. However, to our knowledge, no case of kidney biopsy-proven heme-pigment nephropathy due to hemolysis from a transurethral resection of the prostate procedure has been published to date. Case description: We describe a case of an 82-year-old man with metastatic prostate cancer who presented with severe oliguric renal failure 2 weeks after transurethral resection of the prostate for bladder outlet obstruction. Laboratory studies showed evidence of hemolysis, and a kidney biopsy showed heme-pigment cast nephropathy. Conclusions: We hypothesize that the patient's kidney injury was induced by hemolysis resulting from rapid absorption of hypotonic fluid administered during the transurethral resection of the prostate procedure. Patients with prostate cancer undergoing transurethral resection of the prostate for bladder outlet obstruction may experience severe complications related to rapid absorption of hypotonic fluid. Our case illustrates the importance of nephrology evaluation and kidney biopsy in patients with benign and malignant prostate conditions who experience post-transurethral resection of the prostate syndrome and acute kidney injury in order to better characterize these complications, and to develop preventative strategies for future cases.
Introduction
Transurethral resection of the prostate (TURP) is a common surgical procedure performed in men greater than 60 years of age, usually to relieve bladder outlet obstruction due to benign prostatic hypertrophy. 1 Less commonly, TURP is performed to relieve bladder outlet obstruction in patients with metastatic prostate cancer. Rapid systemic absorption of large amounts of hypotonic irrigation fluid used intraoperatively can lead to acute hyponatremia and neurologic complications, or "TURP syndrome." Post-TURP acute kidney injury (AKI) is uncommon and, in general, poorly characterized in the literature. Here, we describe a patient with metastatic prostate cancer and bladder outlet obstruction who experienced severe post-TURP AKI due to heme-pigment nephropathy as demonstrated on kidney biopsy.
Case report
An 82-year-old African American man with a past medical history of stage IV prostate cancer, urethral strictures, and stage 3A chronic kidney disease (CKD) (baseline serum creatinine (SCr) 1.6 mg/dL, estimated glomerular filtration rate (eGFR) 46 mL/min by CKD-epidemiology calculation) presented to his urologist complaining of dysuria and weak force of urinary stream. His SCr at that time was noted to be 2.1 mg/dL (eGFR 33 mL/min), and his prostate-specific antigen (PSA) had increased to 10.9 ng/mL from 3.7 ng/mL 1 year earlier. His post-void urinary residual volume was 315 mL. Urinalysis was notable for moderate blood, trace protein, small leukocyte esterase, positive nitrite, 40 isomorphic red blood cells per highpowered field (RBCs/hpf), and 50 white blood cells/hpf. A cystoscopy revealed a bulbar urethral stricture and findings concerning for regrowth of prostatic tissue. He was started on ciprofloxacin and tamsulosin and 2 weeks later underwent TURP utilizing 1.5% glycine irrigation fluid. No immediate perioperative complications were noted and he was discharged home with an indwelling urinary catheter on tramadol, nifedipine, pravastatin, enalapril, metoprolol, and cephalexin.
Twelve days later, he presented to our institution with a 2-day history of weakness, fatigue, and tremors. He denied fevers, chills, flank pain, or problems with indwelling urinary catheter drainage. On presentation, he was afebrile, blood pressure was 172/92 mmHg, pulse was 91 beats per minute, and his oxygen saturation was 95% on room air. His neurologic exam was notable for the patient being alert and oriented to person and place only, without focal neurologic deficits. He did not exhibit any edema or rash. Laboratory evaluation revealed a SCr of 31.0 mg/dL, blood urea nitrogen of 172 mg/dL (normal range 8-20 mg/ dL), serum potassium of 8.8 mmol/L (3.5-5.1 mmol/L), serum sodium of 133 mEq/L (136-144 mEq/L), and a serum bicarbonate of 9 mmol/L (22-28 mmol/L). A urinalysis showed red, cloudy urine with moderate bilirubin, trace ketones, large blood, moderate protein, large leukocyte esterase, positive nitrite, too numerous to count RBCs/ hpf, many white blood cells clumps, and many budding yeast. The patient was also noted to have new-onset anemia with hemoglobin of 8.7 g/dL (previous baseline 13.8 g/dL) ( Table 1 ). An electrocardiography (EKG) revealed peaked T-waves. His urine output was 150 mL on the first day of admission. After initiating medical management for hyperkalemia, a dialysis catheter was placed and he was initiated on intermittent hemodialysis.
The workup for his AKI and anemia included a urine protein:creatinine ratio of 37. On hospital day 12, he underwent a kidney biopsy. Light microscopy revealed renal cortex with unremarkable glomeruli. The interstitium contained a moderate mixed inflammatory infiltrate with edema. Tubules showed severe acute injury with luminal ectasia, epithelial flattening, and sloughing. Scattered intratubular casts composed of eosinophilic material were present (Figure 1(a) and (b) ). Immunohistochemistry showed the casts to stain strongly with anti-hemoglobin stain, while anti-myoglobin stain was negative (Figure 1(c) and (d) ). Immunofluorescence microscopy showed no significant staining and electron microscopy showed normal glomerular ultrastructure. Based on these findings, a diagnosis of hemoglobin cast nephropathy was made. The patient did not recover renal function, and remains dialysis-dependent 1 year after presentation.
Discussion
Prostate cancer is the third most common cancer diagnosis in the United States, with 161,360 new cases and 26,730 prostate cancer-related deaths projected for 2017. It is estimated that approximately 11.6% of American men will be diagnosed with prostate cancer during their lifetime. Approximately 5% of this population will have distant spread at diagnosis, conferring a diagnosis of stage IV prostate cancer. Whereas the 5-year survival for tumors with localized or regional spread is close to 100%, the outlook is far more dismal for patients with stage IV disease, with 5-year survival estimated at barely 30%. 2 TURP is commonly used for diagnosis and treatment of multiple causes of bladder outlet obstruction. Although most commonly used for benign prostatic hypertrophy, up to 22% of TURPs performed in the pre-PSA era revealed prostate cancer on pathology. 3 Since the introduction of PSA as a screening tool, this has dropped to approximately 5%. 4 The procedure itself utilizes irrigating fluids to dilate mucosal spaces, allow for the passage of instruments, improve visualization, and allow for the removal of tissue from the surgical field. Many types of irrigating fluids have been used, many of which are hypotonic ( Table 2 ). The systemic absorption of hypotonic irrigating fluids can lead to "TURP syndrome," a combination of neurological and hemodynamic changes related to acute hypo-osmolality, in 0.8%-20% of cases. 3, 5, 6 The incidence of post-TURP AKI has been described in the literature, utilizing myriad definitions of AKI, from less than 1% to up to 50% in patients who develop severe TURP syndrome ("severe" defined as hyponatremia < 120 mmol/L; although hyponatremia is generally a feature and suggestive of TURP syndrome, the diagnosis itself is considered clinical). 8, 9 The mechanism of post-TURP AKI is described primarily in case reports and series, most of which are based on clinical diagnoses and not supported by kidney biopsies. These include ischemic injury from hypotension, hemolytic events, rhabdomyolysis, and renal edema. 8,9 Kim et al. described three patients who experienced severe post-TURP AKI (with two patients requiring hemodialysis) by post-operative day 1, with kidney biopsies showing acute tubular necrosis with negative hemoglobin and myoglobin staining. The authors' hypothesis was that the injury was precipitated by reflux of irrigation fluid caused by increased intravesicular pressure generated during the TURP procedure. 10 Hemolysis has been described as a complication of TURP due to absorption of hypotonic fluids, which reduces the relative tonicity of the local microenvironment, leading to cellular lysis via osmotic shift. Hung et al. 11 reported a case of a 72-year-old male with CKD who underwent TURP using distilled water, and became oliguric 24 h post-procedure. Although this patient was also started on hemodialysis for treatment of his AKI, he recovered adequate renal function for this to be discontinued after six sessions. Retrospective evaluation of the serum osmolalities revealed a low serum osmolality and hyponatremia immediately following TURP. Similar to our patient, they noted a drop in hematocrit and haptoglobin with elevated LDH and reticulocyte counts, leading them to conclude that heme-pigment nephropathy was the etiology of the renal failure. No renal biopsy was performed on their patient, however. 11 In a retrospective case series, Beal et al. examined 49 patients who underwent TURP with spinal anesthesia, 24 who were exposed to distilled water, and 25 who were exposed to 1.5% glycine. Comparable reductions in hematocrit were noted in both groups, and free bilirubin concentration, which was used as a surrogate for hemolysis, was noted to be statistically higher in both groups. One patient in the glycine group was noted to have oliguric AKI following a venous sinus perforation, though no kidney biopsy was performed, and no mechanism for injury was identified or proposed. 12 Heme-pigment nephropathy has been implicated as the cause of post-TURP AKI in multiple other reports, but to our knowledge, our patient is the first known case to have biopsy-proven heme-pigment nephropathy after TURP.
Prevention or early recognition of TURP syndrome has been recommended as a mainstay of management. These recommendations include preoperative risk stratification using prostatic volume, presence of CKD or smoking status, and consideration of bipolar TURP or laser techniques for patients with these identified risk factors; these technologies utilize different irrigation fluids such as normal saline, though this may precipitate volume overload in patients with a history of chronic kidney or cardiopulmonary disease. Nephrology consultation prior to procedure may help to stratify patients and identify strategies to prevent complications. Intraoperatively, strategies to reduce irrigation pressures and operative times may help to limit absorption of irrigation fluid. Post-operative lab monitoring of serum sodium, creatinine, and osmolality has been suggested, with recommendations to further test for hemolysis and rhabdomyolysis if an AKI is identified. Spinal anesthesia has also been suggested over general anesthesia to allow for early identification of symptoms. 9, 13 The large quantity of proteinuria observed in our patient was atypical for a non-glomerular process. High urine protein:creatinine ratios have been reported in other cases of predominantly tubular injury, hypothesized to occur due to decreased reabsorption of filtered albumin by damaged proximal tubules and impairment in tubular creatinine secretion. 14 In summary, patients with prostate cancer may undergo TURP for bladder outlet obstruction and may experience severe complications related to rapid absorption of hypotonic fluid. Our case illustrates the importance of nephrology evaluation and kidney biopsy in patients with benign and malignant prostate conditions who experience post-TURP syndrome and AKI in order to better characterize these complications, and to develop preventative strategies for future cases. 
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